Abstract
The appearance of protein aggregates is a common pathological hallmark that is associated with Alzheimer's disease and other major neurodegenerative disorders. Misfolded and damaged proteins that accumulate in neurodegenerative disease can be cleared through the ubiquitin proteasome system (UPS), a highly regulated pathway whose proper function is of paramount importance in the selective degradation of protein. Studies of the UPS have shown that alterations in the activity of this complex system may be contributors in the etiology of specific neurodegenerative disorders. Studies of familial genetic mutations and through experimental manipulation have suggested that a failure to clear toxic proteins through the UPS may exert important effect on the progression of these disorders; in addition, the accumulation of hallmark proteins themselves may in turn impair clearance by this pathway. This review will discuss recent observations indicating that alterations in the function and efficiency of the UPS are contributors in pathogenesis of Alzheimer’s disease, and discuss whether modulation of the UPS may be an appropriate therapeutic target in Alzheimer's disease and similar neurological disorders.
Keywords: Neurodegenerative diseases, ubiquitin proteasome system, Alzheimer’s disease, ubiquitin, protein degradation, amyloid, tau, ubiquitin-like proteins.
Current Enzyme Inhibition
Title:Therapeutic Targets in the Ubiquitin-proteasome System for Alzheimer's Disease
Volume: 9 Issue: 1
Author(s): Jason L. Eriksen
Affiliation:
Keywords: Neurodegenerative diseases, ubiquitin proteasome system, Alzheimer’s disease, ubiquitin, protein degradation, amyloid, tau, ubiquitin-like proteins.
Abstract: The appearance of protein aggregates is a common pathological hallmark that is associated with Alzheimer's disease and other major neurodegenerative disorders. Misfolded and damaged proteins that accumulate in neurodegenerative disease can be cleared through the ubiquitin proteasome system (UPS), a highly regulated pathway whose proper function is of paramount importance in the selective degradation of protein. Studies of the UPS have shown that alterations in the activity of this complex system may be contributors in the etiology of specific neurodegenerative disorders. Studies of familial genetic mutations and through experimental manipulation have suggested that a failure to clear toxic proteins through the UPS may exert important effect on the progression of these disorders; in addition, the accumulation of hallmark proteins themselves may in turn impair clearance by this pathway. This review will discuss recent observations indicating that alterations in the function and efficiency of the UPS are contributors in pathogenesis of Alzheimer’s disease, and discuss whether modulation of the UPS may be an appropriate therapeutic target in Alzheimer's disease and similar neurological disorders.
Export Options
About this article
Cite this article as:
L. Eriksen Jason, Therapeutic Targets in the Ubiquitin-proteasome System for Alzheimer's Disease, Current Enzyme Inhibition 2013; 9 (1) . https://dx.doi.org/10.2174/1573408011309010007
DOI https://dx.doi.org/10.2174/1573408011309010007 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Is Atorvastatin Superior to Other Statins? Analysis of the Clinical Trials with Atorvastatin Having Cardiovascular Endpoints
Reviews on Recent Clinical Trials The Therapeutic Potential of Purinergic Receptors in Alzheimer’s Disease and Promising Therapeutic Modulators
Mini-Reviews in Medicinal Chemistry Commentary Research Highlights (Amyloid and Alzheimer's Disease: Easing the Load)
CNS & Neurological Disorders - Drug Targets Gastrointestinal Hemorrhage is Associated with Mortality after Acute Ischemic Stroke
Current Neurovascular Research The Role of Stem Cell Factor and Granulocyte-Colony Stimulating Factor in Treatment of Stroke
Recent Patents on CNS Drug Discovery (Discontinued) The Role of the Cell Surface LRP and Soluble LRP in Blood-Brain Barrier Aβ Clearance in Alzheimers Disease
Current Pharmaceutical Design Early Functional and Structural Microvascular Changes in Hypertension Related to Aging
Current Hypertension Reviews Extracellular Superoxide Dismutase (EC-SOD) Quenches Free Radicals and Attenuates Age-Related Cognitive Decline: Opportunities for Novel Drug Development in Aging
Current Alzheimer Research Relations of Magnesium Intake with Metabolic Risk Factors and Risks of Type 2 Diabetes, Hypertension, and Cardiovascular Disease: A Critical Appraisal
Current Nutrition & Food Science Breathing Generation and Potential Pharmacotherapeutic Approaches to Central Respiratory Disorders
Current Medicinal Chemistry Efficacy and Safety Profile of Aliskiren: Practical Implications for Clinicians
Current Drug Safety Preface
Current Enzyme Inhibition Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
Current Vascular Pharmacology Semantic Dementia: A Mini-Review
Mini-Reviews in Medicinal Chemistry Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy
Current Alzheimer Research Association and Causal Relationship of Midlife Obesity and Related Metabolic Disorders with Old Age Cognition
Current Alzheimer Research Impacts of Hyper-Homocysteinemia and White Matter Hyper-Intensity in Alzheimers Disease Patients with Normal Creatinine: An MRI-Based Study with Longitudinal Follow-up
Current Alzheimer Research Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study
Current Pharmaceutical Design Outcomes of Perilla Seed Oil as an Additional Neuroprotective Therapy in Patients with Mild to Moderate Dementia: A Randomized Control Trial
Current Alzheimer Research Imaging Amyloid Pathology in the Living Brain
Current Medical Imaging